ASSESSING AND MODELLING DIGITAL RISKS IN PHARMACEUTICAL INDUSTRY

Authors

  • Sanika Gokhale, Pramod Damle

Abstract

Companies across all sectors, including Pharmaceutical, are progressively making a shift
to a more technology-based work. Work from Home had challenges but the businesses have been
able to cope with this shift, with some companies like TCS claiming that by 2025, 75% of the
workforce would be working from home. While businesses are adapting to this new work style,
the need for managing risk that is associated with it is also growing. Digital and technology
transformation have various risks attached to it and managing them is crucial. Digital risk is any
risk that is caused when a business goes Digital. Each industry faces potential risks and
identifying these risks and working towards securing it, is important. Businesses can face data
loss, theft of critical data, privacy breaches due to digital shifts in the business. Businesses can
face risks related to automation of businesses, and compliance. This study focuses on a detailed
qualitative analysis of perspectives and experiences of the subject matter experts working in the
pharmaceutical industry and coding the data to generate detailed inferences and conclusions from
the codes

Downloads

Download data is not yet available.

Downloads

Published

2020-12-02

How to Cite

Sanika Gokhale, Pramod Damle. (2020). ASSESSING AND MODELLING DIGITAL RISKS IN PHARMACEUTICAL INDUSTRY. PalArch’s Journal of Archaeology of Egypt / Egyptology, 17(6), 4588 - 4597. Retrieved from http://mail.palarch.nl/index.php/jae/article/view/1708